Insulin aspart, recombinant Subcutaneous and Potassium aminobenzoate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Potassium aminobenzoate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: potassium aminobenzoate
Brand name: Potaba
Synonyms: Potassium P-Aminobenzoate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Potassium and sodium phosphate
- Insulin aspart, recombinant Subcutaneous-Potassium bicarbonate
- Insulin aspart, recombinant Subcutaneous-Potassium bicarbonate and potassium chloride
- Insulin aspart, recombinant Subcutaneous-Potassium Bicarbonate and Potassium Citrate
- Insulin aspart, recombinant Subcutaneous-Potassium Bicarbonate Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Potassium Chloride
- Potassium aminobenzoate-Insulin degludec
- Potassium aminobenzoate-Insulin Degludec (U-100) Prefilled Pens
- Potassium aminobenzoate-Insulin Degludec (U-100) Vials
- Potassium aminobenzoate-Insulin Degludec (U-200) Prefilled Pens
- Potassium aminobenzoate-Insulin degludec and liraglutide
- Potassium aminobenzoate-Insulin degludec and liraglutide Subcutaneous